Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | bromodomain adjacent to zinc finger domain, 2B | Starlite/ChEMBL | No references |
Homo sapiens | ubiquitin specific peptidase 1 | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | zinc finger protein | 0.0024 | 0.0411 | 0.089 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.4616 | 1 |
Brugia malayi | RNA binding protein | 0.0076 | 0.4616 | 0.4068 |
Schistosoma mansoni | bromodomain containing protein | 0.0076 | 0.461 | 0.9986 |
Schistosoma mansoni | hypothetical protein | 0.0025 | 0.0513 | 0.111 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.4616 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.4616 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.5325 | 0.5245 |
Echinococcus granulosus | zinc finger protein | 0.0024 | 0.0411 | 0.0545 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.4616 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.2627 | 0.2501 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.4616 | 1 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0027 | 0.0696 | 0.1186 |
Trypanosoma cruzi | ISWI complex protein | 0.0018 | 0 | 0.5 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.4616 | 0.4524 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0027 | 0.0696 | 0.1508 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.2217 | 0.2083 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0043 | 0.1982 | 0.4078 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0072 | 0.4266 | 0.9213 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0021 | 0.0169 | 0.0365 |
Brugia malayi | Bromodomain containing protein | 0.0091 | 0.5736 | 0.5302 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.4616 | 1 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0021 | 0.0227 | 0.006 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 1 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.4616 | 0.4524 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0021 | 0.0169 | 0.0365 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.4616 | 0.4068 |
Trypanosoma brucei | ISWI complex protein | 0.0018 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.2444 | 0.2314 |
Leishmania major | hypothetical protein, conserved | 0.0018 | 0 | 0.5 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0027 | 0.0696 | 0.1186 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0043 | 0.1982 | 0.4078 |
Brugia malayi | Bromodomain containing protein | 0.0046 | 0.221 | 0.1417 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0072 | 0.4266 | 0.9213 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0021 | 0.0169 | 0.0365 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.4616 | 1 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.4616 | 0.4068 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.4616 | 0.4524 |
Echinococcus multilocularis | zinc finger protein | 0.0024 | 0.0411 | 0.0545 |
Trypanosoma cruzi | ISWI complex protein | 0.0018 | 0 | 0.5 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0025 | 0.0513 | 0.035 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0021 | 0.0169 | 0.0365 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 7.9433 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 7.9433 uM | PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 125.8925 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.